Green Bioactives, a Scottish biotechnology company specializing in sustainable plant-based natural products, has secured a grant of up to £1.1 million from Scottish Enterprise. This funding will support an 18-month research and development project focused on scaling up the production of plant-derived bioactive ingredients using the company’s proprietary Plant Cell Culture Technology platform.
“Green Bioactives is a prime example of the kind of ambitious and innovative companies we are keen to see scale-up in Scotland”
The project will help enhance the company’s ability to meet growing demand for eco-friendly and ethically sourced ingredients. Green Bioactives plans to use the grant to expand its production capabilities, ultimately enabling the company to offer viable alternatives to conventional bioactive ingredients sourced from wild-harvesting or synthetic processes.
Leah Pape, head of high growth services at Scottish Enterprise, stated, “Green Bioactives is a prime example of the kind of ambitious and innovative companies we are keen to see scale-up in Scotland. We are proud to support this growth, which has the potential to make a significant impact on the skincare industry and Scotland’s economy.”
Strengthening R&D and manufacturing efforts
This funding is the latest in a series of investments from Scottish Enterprise, which has previously supported Green Bioactives through both financial assistance and advisory services. The ongoing support reflects the company’s progress as it seeks to expand its research and development efforts and manufacturing capabilities.
Dr. David McElroy, CEO of Green Bioactives, expressed his appreciation for the continued backing, noting, “This funding allows us to accelerate the progress of our biomanufacturing platform. We believe it will transform the sustainable production of high-value, plant-derived ingredients across multiple industries.”
